Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market
Holding VRAX?
Track your performance easily

Virax Biolabs Group Ltd. Class A (VRAX) Similar Stocks

33 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Virax Biolabs Group Ltd. Class A
-0.27
-71.82%
Vericel
$2.36B
-9,150.94
25.06%
5 Buy
0 Hold
0 Sell
Strong Buy
Verastem
$85.09M
-0.76
-62.87%
6 Buy
0 Hold
0 Sell
Strong Buy
Veracyte
$1.74B
-24.34
-23.96%
4 Buy
0 Hold
0 Sell
Strong Buy
vTv Therapeutics
$67.76M
-2.54
-20.74%

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
VRAX
Virax Biolabs Group Ltd. Class A
1.13
-2.57
-69.46%
VCEL
Vericel
48.50
15.58
47.33%
VSTM
Verastem
3.36
-7.21
-68.21%
VCYT
Veracyte
22.75
-3.49
-13.30%
VTVT
vTv Therapeutics
22.51
-2.93
-11.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis